[Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
Eleven children suffering from juvenile spondylitis and reactive arthritis not responding to antiinflammatory therapy were treated with sulfasalazine. Eight patients showed good response, in two patients no improvement was seen and in one therapy was stopped because of side effects. This overall successful result of sulfasalazine therapy of juvenile spondylitis should encourage clinicians to plan controlled trials.
Kinderpoliklinik, Universität München.
H J
HJ
Suschke
D000293:Adolescent; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D016918:Arthritis, Reactive / Q000188:drug therapy*; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D016059:Range of Motion, Articular / Q000187:drug effects; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use*
D012460:Sulfasalazine
Die Behandlung der juvenilen Spondylarthritis und der reaktiven Arthritis mit Sulfasalazin.